These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17929140)

  • 41. Interstitial lung disease associated with leflunomide.
    Ito S; Sumida T
    Intern Med; 2004 Dec; 43(12):1103-4. PubMed ID: 15645640
    [No Abstract]   [Full Text] [Related]  

  • 42. Leflunomide for active rheumatoid arthritis.
    Ferraccioli GF; De Vita S
    Lancet; 1999 May; 353(9167):1883; author reply 1883-4. PubMed ID: 10359440
    [No Abstract]   [Full Text] [Related]  

  • 43. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 44. [Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review].
    Molina Molina MI; Pinochet Paiva CM; Quezada Morales JI
    Medwave; 2015 Dec; 15(11):e6350. PubMed ID: 26819061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe pancytopenia following etanercept administration in rheumatoid arthritis.
    Martínez Santana V; Izquierdo Navarro M; Calleja Hernández MÁ; Sánchez Sánchez T; Sainz Gil M
    Int J Rheum Dis; 2012 Aug; 15(4):e78-9. PubMed ID: 22898233
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute hepatitis associated to leflunomide in a patient with rheumatoid arthritis.
    Chávez-López MA; Ramírez-González A; Martínez-Guevara MA
    Gastroenterol Hepatol; 2007; 30(7):430. PubMed ID: 17692207
    [No Abstract]   [Full Text] [Related]  

  • 47. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
    Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
    Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide.
    Martinez-Taboada VM; Rodriguez-Valverde V; Gonzalez-Vilchez F; Armijo JA
    Rheumatology (Oxford); 2004 Nov; 43(11):1451-3. PubMed ID: 15501999
    [No Abstract]   [Full Text] [Related]  

  • 49. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
    Toth P; Bernd R
    Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rheumatoid arthritis and the Arava (leflunomide) controversy.
    Turkoski BB
    Orthop Nurs; 2003; 22(1):48-51. PubMed ID: 12640952
    [No Abstract]   [Full Text] [Related]  

  • 51. Leflunomide-associated weight loss in rheumatoid arthritis.
    Coblyn JS; Shadick N; Helfgott S
    Arthritis Rheum; 2001 May; 44(5):1048-51. PubMed ID: 11352235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
    McEwen J; Purcell PM; Hill RL; Calcino LJ; Riley CG
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):65-73. PubMed ID: 16634119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interstitial lung disease and disease modifying anti-rheumatic drugs.
    Scott DL
    Lancet; 2004 Apr; 363(9416):1239-40. PubMed ID: 15081669
    [No Abstract]   [Full Text] [Related]  

  • 54. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
    Wolfe F; Michaud K; Stephenson B; Doyle J
    J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Elias AR; Tam CC; David-Bajar KM
    Cutis; 2005 Sep; 76(3):189-92. PubMed ID: 16268263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple eruptive keratoacanthomas associated with leflunomide.
    Frances L; Guijarro J; Marin I; Leiva-Salinas Mdel C; Bouret AM
    Dermatol Online J; 2013 Jul; 19(7):18968. PubMed ID: 24010514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Leflunomide-induced toxic epidermal necrolysis].
    El Aïdli S; Salouage I; Kastalli S; Srairi S; Daghfous R; Loueslati MH; Belkahia C
    Therapie; 2008; 63(2):157-8. PubMed ID: 18677817
    [No Abstract]   [Full Text] [Related]  

  • 59. Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient.
    Ricci M; Rossi P; De Marco G; Varisco V; Marchesoni A
    Rheumatology (Oxford); 2010 Oct; 49(10):2001. PubMed ID: 20601656
    [No Abstract]   [Full Text] [Related]  

  • 60. Leflunomide-induced aseptic meningitis.
    Cohen JD; Jorgensen C; Sany J
    Joint Bone Spine; 2004 May; 71(3):243-5. PubMed ID: 15182800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.